| Major depression in elderly home health care patients ML Bruce, GJ McAvay, PJ Raue, EL Brown, BS Meyers, DJ Keohane, ... American Journal of psychiatry 159 (8), 1367-1374, 2002 | 523 | 2002 |
| Predictors of self-neglect in community-dwelling elders RC Abrams, M Lachs, G McAvay, DJ Keohane, ML Bruce American Journal of Psychiatry 159 (10), 1724-1730, 2002 | 277 | 2002 |
| The role of general practitioners in the diagnosis and treatment of Alzheimer's disease: a multinational survey D Wilkinson, C Stave, D Keohane, O Vincenzino Journal of International Medical Research 32 (2), 149-159, 2004 | 122 | 2004 |
| Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy M Waddington Cruz, L Amass, D Keohane, J Schwartz, H Li, ... Amyloid 23 (3), 178-183, 2016 | 106 | 2016 |
| Potential clinical and economic impact of switching branded medications to generics RJ Straka, DJ Keohane, LZ Liu American journal of therapeutics 24 (3), e278-e289, 2017 | 81 | 2017 |
| Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin‐norepinephrine reuptake inhibitors in older adults: a network meta‐analysis K Thorlund, E Druyts, P Wu, C Balijepalli, D Keohane, E Mills Journal of the American Geriatrics Society 63 (5), 1002-1009, 2015 | 81 | 2015 |
| Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial D Keohane, J Schwartz, B Gundapaneni, M Stewart, L Amass Amyloid 24 (1), 30-36, 2017 | 58 | 2017 |
| Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy BK Gundapaneni, MB Sultan, DJ Keohane, JH Schwartz European Journal of Neurology 25 (3), 464-468, 2018 | 42 | 2018 |
| Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis SB Dybicz, DJ Keohane, WG Erwin, T McRae, SN Shah The American journal of geriatric pharmacotherapy 4 (2), 154-160, 2006 | 37 | 2006 |
| Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy HHJ Schmidt, F Barroso, A González‐Duarte, I Conceição, L Obici, ... Muscle & Nerve 54 (3), 353-360, 2016 | 36 | 2016 |
| Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses GJ DiGregorio, AP Ferko, EJ Barbieri, EK Ruch, H Chawla, D Keohane, ... Journal of analytical toxicology 18 (5), 247-250, 1994 | 33 | 1994 |
| Positive effectiveness of tafamidis in delaying disease progression in transthyretin familial amyloid polyneuropathy up to 2 years: an analysis from the Transthyretin … R Mundayat, M Stewart, J Alvir, S Short, ML Ong, D Keohane, D Rill, ... Neurology and Therapy 7, 87-101, 2018 | 29 | 2018 |
| Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT J Nativi‐Nicolau, DP Judge, JE Hoffman, B Gundapaneni, D Keohane, ... ESC Heart Failure 8 (5), 3875-3884, 2021 | 26 | 2021 |
| One-month stability of depression among elderly home-care patients PJ Raue, BS Meyers, GJ McAvay, EL Brown, D Keohane, ML Bruce The American journal of geriatric psychiatry 11 (5), 543-550, 2003 | 26 | 2003 |
| Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy L Amass, H Li, BK Gundapaneni, JH Schwartz, DJ Keohane Orphanet Journal of Rare Diseases 13, 1-7, 2018 | 17 | 2018 |
| A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes … T Coelho, I Conceição, M Waddington-Cruz, D Keohane, MB Sultan, ... Amyloid 29 (4), 228-236, 2022 | 14 | 2022 |
| Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial D Keohane, J Schwartz, B Gundapaneni, M Stewart, L Amass Orphanet Journal of Rare Diseases 10 (1), 1-2, 2015 | 4 | 2015 |
| Ziprasidone and the relative risk of diabetes D Vanderburg, D Keohane, ON Karayal, E Pappadopulos The British Journal of Psychiatry 198 (2), 157-158, 2011 | 4 | 2011 |
| Retrospective analysis of characteristics in long-term care residents with Alzheimer's disease continuing versus discontinuing donepezil treatment SN Shah, D Keohane, BD Strunk, B Mercadante, T McRae, D Smith NEUROBIOLOGY OF AGING 25, S186-S186, 2004 | 4 | 2004 |
| Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study L Ponti, K Hsu, T Damy, E Villacorta, N Verheyen, D Keohane, R Wang, ... Frontiers in Cardiovascular Medicine 10, 1238843, 2023 | 2 | 2023 |
